Literature DB >> 21057505

Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence.

Kaori Fujita1, Izumi Horikawa, Abdul M Mondal, Lisa M Miller Jenkins, Ettore Appella, Borivoj Vojtesek, Jean-Christophe Bourdon, David P Lane, Curtis C Harris.   

Abstract

The telomere-capping complex shelterin protects functional telomeres and prevents the initiation of unwanted DNA-damage-response pathways. At the end of cellular replicative lifespan, uncapped telomeres lose this protective mechanism and DNA-damage signalling pathways are triggered that activate p53 and thereby induce replicative senescence. Here, we identify a signalling pathway involving p53, Siah1 (a p53-inducible E3 ubiquitin ligase) and TRF2 (telomere repeat binding factor 2; a component of the shelterin complex). Endogenous Siah1 and TRF2 were upregulated and downregulated, respectively, during replicative senescence with activated p53. Experimental manipulation of p53 expression demonstrated that p53 induces Siah1 and represses TRF2 protein levels. The p53-dependent ubiquitylation and proteasomal degradation of TRF2 are attributed to the E3 ligase activity of Siah1. Knockdown of Siah1 stabilized TRF2 and delayed the onset of cellular replicative senescence, suggesting a role for Siah1 and TRF2 in p53-regulated senescence. This study reveals that p53, a downstream effector of telomere-initiated damage signalling, also functions upstream of the shelterin complex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057505      PMCID: PMC3470109          DOI: 10.1038/ncb2123

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  59 in total

1.  Senescence induced by altered telomere state, not telomere loss.

Authors:  Jan Karlseder; Agata Smogorzewska; Titia de Lange
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

Review 2.  Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology.

Authors:  W E Wright; J W Shay
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

3.  The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo.

Authors:  André Lechel; Ande Satyanarayana; Zhenyu Ju; Ruben R Plentz; Sonja Schaetzlein; Cornelia Rudolph; Ludwig Wilkens; Stephanie U Wiemann; Gabriele Saretzki; Nisar P Malek; Michael P Manns; Jan Buer; K Lenhard Rudolph
Journal:  EMBO Rep       Date:  2005-03       Impact factor: 8.807

4.  Exploring mechanisms of the DNA-damage response: p53 pulses and their possible relevance to apoptosis.

Authors:  Tongli Zhang; Paul Brazhnik; John J Tyson
Journal:  Cell Cycle       Date:  2007-01-12       Impact factor: 4.534

5.  SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1).

Authors:  J P Roperch; F Lethrone; S Prieur; L Piouffre; D Israeli; M Tuynder; M Nemani; P Pasturaud; M C Gendron; J Dausset; M Oren; R B Amson; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

6.  Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization.

Authors:  F Z Bischoff; S O Yim; S Pathak; G Grant; M J Siciliano; B C Giovanella; L C Strong; M A Tainsky
Journal:  Cancer Res       Date:  1990-12-15       Impact factor: 12.701

7.  Role of the TRF2 telomeric protein in cancer and ageing.

Authors:  Purificación Muñoz; Raquel Blanco; María A Blasco
Journal:  Cell Cycle       Date:  2006-04-01       Impact factor: 4.534

8.  Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.

Authors:  Dietrich B Conze; Chuan-Jin Wu; James A Thomas; Allison Landstrom; Jonathan D Ashwell
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

9.  The shelterin protein TRF2 inhibits Chk2 activity at telomeres in the absence of DNA damage.

Authors:  Giacomo Buscemi; Laura Zannini; Enrico Fontanella; Daniele Lecis; Sofia Lisanti; Domenico Delia
Journal:  Curr Biol       Date:  2009-04-16       Impact factor: 10.834

Review 10.  The ups and downs of p53: understanding protein dynamics in single cells.

Authors:  Eric Batchelor; Alexander Loewer; Galit Lahav
Journal:  Nat Rev Cancer       Date:  2009-04-09       Impact factor: 60.716

View more
  49 in total

1.  Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.

Authors:  Y Tang; I Horikawa; M Ajiro; A I Robles; K Fujita; A M Mondal; J K Stauffer; Z-M Zheng; C C Harris
Journal:  Oncogene       Date:  2012-07-09       Impact factor: 9.867

Review 2.  Fusing telomeres with RNF8.

Authors:  Jacqueline J L Jacobs
Journal:  Nucleus       Date:  2012-03-01       Impact factor: 4.197

3.  Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation.

Authors:  Marzia Fumagalli; Francesca Rossiello; Michela Clerici; Sara Barozzi; Davide Cittaro; Jessica M Kaplunov; Gabriele Bucci; Miryana Dobreva; Valentina Matti; Christian M Beausejour; Utz Herbig; Maria Pia Longhese; Fabrizio d'Adda di Fagagna
Journal:  Nat Cell Biol       Date:  2012-03-18       Impact factor: 28.824

4.  Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway.

Authors:  Irmina Diala; Nicole Wagner; Frédérique Magdinier; Marina Shkreli; Maria Sirakov; Serge Bauwens; Caroline Schluth-Bolard; Thomas Simonet; Valérie M Renault; Jing Ye; Abdelnnadir Djerbi; Pascal Pineau; Jinkuk Choi; Steven Artandi; Anne Dejean; Michelina Plateroti; Eric Gilson
Journal:  EMBO Rep       Date:  2013-02-22       Impact factor: 8.807

Review 5.  Transcriptional outcome of telomere signalling.

Authors:  Jing Ye; Valérie M Renault; Karine Jamet; Eric Gilson
Journal:  Nat Rev Genet       Date:  2014-06-10       Impact factor: 53.242

6.  Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.

Authors:  Masahiro Kato; Masahiro Nakayama; Minako Agata; Kenichi Yoshida
Journal:  Tumour Biol       Date:  2012-12-18

7.  Heparan sulfation is essential for the prevention of cellular senescence.

Authors:  S H Jung; H C Lee; D-M Yu; B C Kim; S M Park; Y-S Lee; H J Park; Y-G Ko; J-S Lee
Journal:  Cell Death Differ       Date:  2015-08-07       Impact factor: 15.828

Review 8.  Inducing stable reversion to achieve cancer control.

Authors:  Scott Powers; Robert E Pollack
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

Review 9.  Regulators and effectors of Siah ubiquitin ligases.

Authors:  Jianfei Qi; Hyungsoo Kim; Marzia Scortegagna; Ze'ev A Ronai
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

10.  The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism.

Authors:  Mary Ann Suico; Ryosuke Fukuda; Rui Miyakita; Kosuke Koyama; Manabu Taura; Tsuyoshi Shuto; Hirofumi Kai
Journal:  J Biol Chem       Date:  2014-07-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.